During the past decade, Imperial College Hammersmith Campus conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Imperial College Hammersmith Campus" #1 collaborator was "British Heart Foundation" with 2 trials as a collaborator, "Alexander Mosely Charitable Trust" with 1 trials as a collaborator, "Chelsea and Westminster NHS Foundation Trust" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Hammersmith Hospitals NHS Trust" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Imperial College Hammersmith Campus" are "Telangiectasia, Hereditary Hemorrhagic" (6 trials), "Anorexia Nervosa" (1 trials), "Arrhythmia" (1 trials), "Cardiomyopathy, Dilated" (1 trials) and "Chemotherapy Effect" (1 trials). Many other conditions were trialed in "Imperial College Hammersmith Campus" in a lesser frequency.

Most popular intervention types in "Imperial College Hammersmith Campus" are "Drug" (7 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "APR-246" (2 trials), "Blood sample to be taken." (1 trials), "Carboplatin and Pegylated Liposomal Doxorubicin Hydrochloride (PLD)" (1 trials), "Doxorubicin and Cisplatin" (1 trials) and "Electrocardiographic imaging" (1 trials). Other intervention names were less common.

The vast majority of trials in "Imperial College Hammersmith Campus" are 13 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Imperial College Hammersmith Campus". 1 are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Imperial College Hammersmith Campus, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Imperial College Hammersmith Campus, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".